Transcribed gene fusions are key biomarkers in many hematologic and solid tumors, often representing the primary oncogenic driver mutation. Here, we report an experimental and computational pipeline for detecting fusion transcripts using single-molecule RNA FISH and unbiased correlation analysis (FuseFISH). We constructed a genome-wide database of optimal oligonucleotide sequences, enabling quick design of FuseFISH probes against known and novel fusions. We implemented FuseFISH in cell lines, tissue sections, and purified RNA, reliably detecting one BCR-ABL1 positive in 10,000 negative cells. In 34 hematologic samples, we detected BCR-ABL1 transcripts with high specificity and sensitivity. Finally, we measured BCR-ABL1 expression heterogene...
Background Fusion genes are known to be drivers of many common cancers, so they are...
Gene fusions are known to play critical roles in tumor pathogenesis. Yet, sensitive and specific alg...
The identification of gene fusions promises to play an important role in personalized cancer treatme...
Transcribed gene fusions are key biomarkers in many hematologic and solid tumors, often representing...
Transcribed gene fusions are key biomarkers in many hematologic and solid tumors, often representing...
Transcribed gene fusions are key biomarkers in many hematologic and solid tumors, often representing...
SummaryTranscribed gene fusions are key biomarkers in many hematologic and solid tumors, often repre...
<div><p>Double-stranded DNA breaks occur on a regular basis in the human genome as a consequence of ...
Gene fusions occur in solid tumors and hematological malignancies, formed as the result of somatic g...
Background: Gene fusions, which result from abnormal chromosome rearrangements, are a pathogenic fac...
Abstract Background In cancer, genomic rearrangements can create fusion genes that either combine pr...
<p>(A) Representation of the organization of the BCR and ABL genes, with arrows indicating reported ...
BACKGROUND: The ability to detect neoplasia-specific fusion genes is important not only in cancer re...
Context.-Next-generation sequencing is a high-throughput method for detecting genetic abnormalities ...
Abstract Background Genomic rearrangements in cancer cells can create fusion genes that encode chime...
Background Fusion genes are known to be drivers of many common cancers, so they are...
Gene fusions are known to play critical roles in tumor pathogenesis. Yet, sensitive and specific alg...
The identification of gene fusions promises to play an important role in personalized cancer treatme...
Transcribed gene fusions are key biomarkers in many hematologic and solid tumors, often representing...
Transcribed gene fusions are key biomarkers in many hematologic and solid tumors, often representing...
Transcribed gene fusions are key biomarkers in many hematologic and solid tumors, often representing...
SummaryTranscribed gene fusions are key biomarkers in many hematologic and solid tumors, often repre...
<div><p>Double-stranded DNA breaks occur on a regular basis in the human genome as a consequence of ...
Gene fusions occur in solid tumors and hematological malignancies, formed as the result of somatic g...
Background: Gene fusions, which result from abnormal chromosome rearrangements, are a pathogenic fac...
Abstract Background In cancer, genomic rearrangements can create fusion genes that either combine pr...
<p>(A) Representation of the organization of the BCR and ABL genes, with arrows indicating reported ...
BACKGROUND: The ability to detect neoplasia-specific fusion genes is important not only in cancer re...
Context.-Next-generation sequencing is a high-throughput method for detecting genetic abnormalities ...
Abstract Background Genomic rearrangements in cancer cells can create fusion genes that encode chime...
Background Fusion genes are known to be drivers of many common cancers, so they are...
Gene fusions are known to play critical roles in tumor pathogenesis. Yet, sensitive and specific alg...
The identification of gene fusions promises to play an important role in personalized cancer treatme...